TEC Results Meeting: Unique Methodology to Render Non-Soluble Compounds Soluble with Nanotechnology

TEC Results Meeting: Unique Methodology to Render Non-Soluble Compounds Soluble with Nanotechnology

LIVE EVENT ONLY

 

Are you involved in Drug Discovery and Development? Are you trying to transform non-soluble compounds into soluble compounds?

The Technology Evaluation Consortium™ (TEC) in One Million Solutions in Health has been working with our Steering Committee and Subject Matter Experts over the last number of months to implement one of our TEC Validation Projects™.

On a trial basis, to share with the broader scientific community the results of the Technology Evaluation Consortium’s work, we are opening up an opportunity for you to have a front-row seat to hear about the results of this TEC Validation Project to transform non-soluble compounds into soluble compounds.

A nano-scale manufacturing process developed by researchers at the Center for High-rate Nanomanufacturing (CHN) at Northeastern University can produce nanorod structures with a unique ability to pass through normal tissue boundaries.  This allows compounds that are normally insoluble to become soluble and be delivered into the body orally.

From compounds chosen and provided by several TEC members, i.e., AbbVie, Allergan, and Janssen, the team at Northeastern University has completed their proof-of-concept study, the data from which will be presented at our Consortium-wide meeting on October 20th at 1pm.

Fundamentally, our mandate is to bring into the TEC the evaluations and validations that the industry wants to implement and, particularly, those that are being done individually by each company, but could be better served by having everyone do them together.  To this end, One Million Solutions in Health™ has been conducting TEC Validation Projects for the last 10 years as part of our mission to:

•        Triage and streamline new technology consideration for the industry.

•        To be the place for the industry to conduct their evaluations and validations.

Normally, this opportunity to learn directly from the scientists and participants would ONLY be made available to members of our Technology Evaluation Consortium™ (TEC). But, right now, this information is being shared beyond our current membership, to provide you and/or your organization with the opportunity to join the consortium. Membership can be on an organization-wide basis, or an individual basis, for industry, academia and/or students.

This is also your opportunity to learn more about our exclusive TEC Validation Project process, where Subject Matter Experts actively participate with technology providers to mold and direct a final offering which best fits the needs of the industry.  By providing feedback directly to the scientists who have created the technology, the consortium is able to accelerate the application of the science into the industry.

We are appreciative of the contributions from AbbVie, Allergan and Janssen, who provided the compounds for this validation project. This Results Meeting on October 20^th will showcase how this nano-scale manufacturing process can produce nanorod structures with a unique ability to pass through normal tissue boundaries. This is important because a significant number of NCEs (New Chemical Entities) developed by the industry are poorly soluble in water and cannot be taken orally.

Current member companies in the Technology Evaluation Consortium include organizations like Pfizer, AbbVie, Allergan, Amgen and Janssen, along with many others. However, for a limited time, we are allowing new industry participants, and other scientists, clinicians and investors in organizations around the world, to learn about this technology and take part in this TEC Validation Project Results Meeting entitled “Unique Methodology to Render Non-Soluble Compounds Soluble with Nanotechnology” on Tuesday, October 20^th at 1pm EST.

Be a part of this exclusive TEC Validation Project presentation by clicking HERE

 

 

 

PANELISTS
	SPEAKER:Ahmed Busnaina, PhD Director Center for High-rate Nanomanufacturing Northeastern University
	SPEAKER:Cihan Yilmaz, PhD Research Associate Center for High-rate Nanomanufacturing Northeastern University
	MODERATOR:Dawn Van Dam President & CEO One Million Solutions in Health™

SIGN ME UP FOR THIS SIGNATURE SQUARE EVENT: Click HERE

Note: This is a live event only. No recording will be available, except to members of the Technology Evaluation Consortium. Contact us for membership information.

MORE INFO ABOUT One Million Solutions in Health:

As a not-for-profit, the goal of One Million Solutions in Health is to shape health care by sharing solutions and, importantly, to accelerate the discovery, development and delivery … of innovative cures, treatments and preventative measures for patients around the world.

In this next year, we will be reviewing 100’s of new solutions and new scientific discoveries. By engaging scientists, entrepreneurs, investors, innovators, industry experts, health care professionals, and patients across various disciplines, and from around the world, we can utilize the power of the internet to disrupt things in a positive and transformative way.

We are on our way towards accelerating high-potential innovations, catalyzing investment and increasing awareness of, and support for, transformative ideas to improve health and save lives. We are thrilled to have you be a part of this transformative journey!